Rosuvastatin Completed Phase 3 Trials for Hyperlipoproteinemia Type III Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00214604Type III Dysbetalipoproteinemia